179 related articles for article (PubMed ID: 22685372)
1. Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis?
Li C; Li S; Jia C; Yang L; Song Z; Wang Y
Mediators Inflamm; 2012; 2012():248574. PubMed ID: 22685372
[TBL] [Abstract][Full Text] [Related]
2. S100A8 and S100A9 promote endothelial cell activation through the RAGE‑mediated mammalian target of rapamycin complex 2 pathway.
Zhong X; Xie F; Chen L; Liu Z; Wang Q
Mol Med Rep; 2020 Dec; 22(6):5293-5303. PubMed ID: 33174028
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells.
Wang L; Luo H; Chen X; Jiang Y; Huang Q
PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267
[TBL] [Abstract][Full Text] [Related]
4. Investigating the extremes of the continuum of paracrine functions in CD34-/CD31+ CACs across diverse populations.
Landers-Ramos RQ; Sapp RM; VandeWater E; Macko J; Robinson S; Wang Y; Chin ER; Spangenburg EE; Prior SJ; Hagberg JM
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H162-H172. PubMed ID: 27793853
[TBL] [Abstract][Full Text] [Related]
5. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.
Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH
Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330
[TBL] [Abstract][Full Text] [Related]
6. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
[TBL] [Abstract][Full Text] [Related]
7. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
Ehlermann P; Eggers K; Bierhaus A; Most P; Weichenhan D; Greten J; Nawroth PP; Katus HA; Remppis A
Cardiovasc Diabetol; 2006 Mar; 5():6. PubMed ID: 16573830
[TBL] [Abstract][Full Text] [Related]
8. The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas.
Li Y; Kong F; Jin C; Hu E; Shao Q; Liu J; He D; Xiao X
BMC Cancer; 2019 Jun; 19(1):597. PubMed ID: 31208368
[TBL] [Abstract][Full Text] [Related]
9. S100A8 and S100A9 in inflammation and cancer.
Gebhardt C; Németh J; Angel P; Hess J
Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
[TBL] [Abstract][Full Text] [Related]
10. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
[TBL] [Abstract][Full Text] [Related]
11. S100A9 has a protective role in inflammation-induced skin carcinogenesis.
McNeill E; Hogg N
Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096
[TBL] [Abstract][Full Text] [Related]
12. SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways.
Du G; Zhu H; Yu P; Wang H; He J; Ye L; Fu F; Zhang J; Tian J
Eur J Pharmacol; 2013 Jan; 700(1-3):173-80. PubMed ID: 23276662
[TBL] [Abstract][Full Text] [Related]
13. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-associated S100 proteins: new mechanisms that regulate function.
Goyette J; Geczy CL
Amino Acids; 2011 Oct; 41(4):821-42. PubMed ID: 20213444
[TBL] [Abstract][Full Text] [Related]
15. S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells.
Qin F; Song Y; Li Z; Zhao L; Zhang Y; Geng L
Pathol Oncol Res; 2010 Sep; 16(3):353-60. PubMed ID: 19957061
[TBL] [Abstract][Full Text] [Related]
16. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
McCormick MM; Rahimi F; Bobryshev YV; Gaus K; Zreiqat H; Cai H; Lord RS; Geczy CL
J Biol Chem; 2005 Dec; 280(50):41521-9. PubMed ID: 16216873
[TBL] [Abstract][Full Text] [Related]
17. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
18. S100A proteins in the pathogenesis of experimental corneal neovascularization.
Li C; Zhang F; Wang Y
Mol Vis; 2010 Oct; 16():2225-35. PubMed ID: 21139687
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic VEGF
Ganta VC; Choi M; Farber CR; Annex BH
Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
[TBL] [Abstract][Full Text] [Related]
20. Localization of S100A8 and S100A9 expressing neutrophils to spinal cord during peripheral tissue inflammation.
Mitchell K; Yang HY; Tessier PA; Muhly WT; Swaim WD; Szalayova I; Keller JM; Mezey E; Iadarola MJ
Pain; 2008 Jan; 134(1-2):216-31. PubMed ID: 18063312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
